The role of cell-Associated virus in motherto-child HIV transmission

Journal of Infectious Diseases

Volumn 210, Issue , 2014, Pages S631-S640

  Milligan, Caitlin ^a,b,c   Overbaugh, Julie ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Breast milk; Cell Associated virus; Cell free virus; Genital secretions; HIV 1; Infected leukocytes; Mother To child transmission.

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADVERSE EFFECTS; ANIMAL; BREAST FEEDING; BREAST MILK; DRUG EFFECTS; FEMALE; HIV INFECTIONS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; NEWBORN; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVENTION AND CONTROL; TRANSMISSION; VERTICAL TRANSMISSION; VIROLOGY;

ANIMALS; ANTI-HIV AGENTS; BREAST FEEDING; FEMALE; HIV; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MILK, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 84925222391     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu344     Document Type: Article

References (111)

1. UNAIDS. Global Report: UNAIDS report on the global AIDS epidemic 2013. 2013.
2. Lehman DA, Farquhar C. Biological mechanisms of vertical human immunodeficiency virus (HIV-1) transmission. Rev Med Virol 2007; 17:381-403.
3. Mofenson LM, Lambert JS, Stiehm ER, et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med 1999; 341:385-93.
4. Dickover RE, Garratty EM, Herman SA, et al. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. JAMA 1996; 275:599-605.
5. John GC, Nduati RW, Mbori-Ngacha DA, et al. Correlates of motherto-child human immunodeficiency virus type 1 (HIV-1) transmission: Association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J Infect Dis 2001; 183:206-12.
6. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal singledose nevirapine compared with zidovudine for prevention of motherto-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999; 354:795-802.
7. European Collaborative Study. Mother-To-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 2005; 40:458-65.
8. Shapiro RL, Hughes MD, Ogwu A, et al. Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med 2010; 362:2282-94.
9. The Kesho Bora Study Group. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-To-child transmission of HIV-1 (Kesho Bora study): A randomised controlled trial. Lancet Infect Dis 2011; 11:171-80.
10. Loussert-Ajaka I, Mandelbrot L, Delmas MC, et al. HIV-1 detection in cervicovaginal secretions during pregnancy. Aids 1997; 11:1575-81.
11. Lewis P, Nduati R, Kreiss JK, et al. Cell-free human immunodeficiency virus type 1 in breast milk. J Infect Dis 1998; 177:34-9.
12. Van de Perre P, Rubbo P-A, Viljoen J, et al. HIV-1 reservoirs in breast milk and challenges to elimination of breast-feeding transmission of HIV-1. Sci Transl Med 2012; 4:143sr3.
13. Henin Y, Mandelbrot L, Henrion R, Pradinaud R, Coulaud JP, Montagnier L. Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women. J Acquir Immune Defic Syndr 1993; 6:72-5.
14. Nduati R, John G, Mbori-Ngacha D, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: A randomized clinical trial. JAMA 2000; 283:1167-74.
15. The International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1-A meta-Analysis of 15 prospective cohort studies. N Engl J Med 1999; 340:977-87.
16. Abel K, Pahar B, Van Rompay KKA, et al. Rapid virus dissemination in infant macaques after oral simian immunodeficiency virus exposure in the presence of local innate immune responses. J Virol 2006; 80:6357-67.
17. Milush JM, Kosub D, Marthas M, et al. Rapid dissemination of SIV following oral inoculation. Aids 2004; 18:2371-80.
18. Bunders MJ, van der Loos CM, Klarenbeek PL, et al. Memory CD4(+) CCR5(+) T cells are abundantly present in the gut of newborn infants to facilitate mother-To-child transmission of HIV-1. Blood 2012; 120:4383-90.
19. Alfsen A, Yu H, Magerus-Chatinet A, Schmitt A, Bomsel M. HIV-1-infected blood mononuclear cells form an integrin-And agrindependent viral synapse to induce efficient HIV-1 transcytosis across epithelial cell monolayer. Mol Biol Cell 2005; 16:4267-79.
20. Bomsel M. Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nat Med 1997; 3:42-7.
21. Tugizov SM, Herrera R, Veluppillai P, et al. HIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells. Virology 2011; 409:211-22.
22. Tugizov SM, Herrera R, Veluppillai P, et al. Differential transmission of HIV traversing fetal oral/intestinal epithelia and adult oral epithelia. J Virol 2012; 86:2556-70.
23. Vidricaire G, Gauthier S, Tremblay MJ. HIV-1 infection of trophoblasts is independent of gp120/CD4 Interactions but relies on heparan sulfate proteoglycans. J Infect Dis 2007; 195:1461-71.
24. Sattentau Q. Avoiding the void: cell-To-cell spread of human viruses. Nat Rev Micro 2008; 6:815-26.
25. Lagaye S, Derrien M, Menu E, et al. Cell-To-cell contact results in a selective translocation of maternal human immunodeficiency virus type 1 quasispecies across a trophoblastic barrier by both transcytosis and infection. J Virol 2001; 75:4780-91.
26. Dimitrov DS, Willey RL, Sato H, Chang LJ, Blumenthal R, Martin MA. Quantitation of human immunodeficiency virus type 1 infection kinetics. J Virol 1993; 67:2182-90.
27. Chen P, Hubner W, Spinelli MA, Chen BK. Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses. J Virol 2007; 81:12582-95.
28. Sourisseau M, Sol-Foulon N, Porrot F, Blanchet F, Schwartz O. Inefficient human immunodeficiency virus replication in mobile lymphocytes. J Virol 2007; 81:1000-12.
29. Bourinbaiar AS. The ratio of defective HIV-1 particles to replicationcompetent infectious virions. Acta Virol 1994; 38:59-61.
30. Ho Y-C, Shan L, Hosmane NN, et al. Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell 2013; 155:540-51.
31. Lewis SH, Reynolds-Kohler C, Fox HE, Nelson JA. HIV-1 in trophoblastic and villous Hofbauer cells, and haematological precursors in eight-week fetuses. Lancet 1990; 335:565-8.
32. Zachar V, Norskov-Lauritsen N, Juhl C, Spire B, Chermann JC, Ebbesen P. Susceptibility of cultured human trophoblasts to infection with human immunodeficiency virus type 1. J Gen Virol 1991; 72(Pt 6): 1253-60.
33. Phillips DM, Tan X. HIV-1 infection of the trophoblast cell line BeWo: A study of virus uptake. AIDS Res Hum Retroviruses 1992; 8:1683-91.
34. Mognetti B, Moussa M, Croitoru J, et al. HIV-1 co-receptor expression on trophoblastic cells from early placentas and permissivity to infection by several HIV-1 primary isolates. Clin Exp Immunol 2000; 119:486-92.
35. David FJ, Autran B, Tran HC, et al. Human trophoblast cells express CD4 and are permissive for productive infection with HIV-1. Clin Exp Immunol 1992; 88:10-6.
36. Ross AL, Cannou C, Barre-Sinoussi F, Menu E. Proteasome-independent degradation of HIV-1 in naturally non-permissive human placental trophoblast cells. Retrovirology 2009; 6:46.
37. Dolcini G, Derrien M, Chaouat G, Barre-Sinoussi F, Menu E. Cell-free HIV type 1 infection is restricted in the human trophoblast choriocarcinoma BeWo cell line, even with expression of CD4, CXCR4 and CCR5. AIDS Res Hum Retroviruses 2003; 19:857-64.
38. Vidricaire G, Imbeault M, Tremblay MJ. Endocytic host cell machinery plays a dominant role in intracellular trafficking of incoming human immunodeficiency virus type 1 in human placental trophoblasts. J Virol 2004; 78:11904-15.
39. Arias RA, Munoz LD, Munoz-Fernandez MA. Transmission of HIV-1 infection between trophoblast placental cells and T-cells take place via an LFA-1-mediated cell to cell contact. Virology 2003; 307:266-77.
40. Fazely F, Sharma PL, Fratazzi C, et al. Simian immunodeficiency virus infection via amniotic fluid: A model to study fetal immunopathogenesis and prophylaxis. J Acquir Immune Defic Syndr 1993; 6:107-14.
41. Ochs HD, Morton WR, Kuller LD, et al. Intra-Amniotic inoculation of pigtailed macaque (Macaca nemestrina) fetuses with SIV and HIV-1. J Med Primatol 1993; 22:162-8.
42. Mundy DC, Schinazi RF, Gerber AR, Nahmias AJ, Randall HWJ. Human immunodeficiency virus isolated from amniotic fluid. Lancet 1987; 2:459-60.
43. Lobato AC, Aguiar RA, Aleixo AW, et al. HIV-1 RNA detection in the amniotic fluid of HIV-infected pregnant women. Mem Inst Oswaldo Cruz 2010; 105:720-1.
44. Maiques V, Garcia-Tejedor A, Perales A, Cordoba J, Esteban RJ. HIV detection in amniotic fluid samples. Amniocentesis can be performed in HIV pregnant women? Eur J Obstet Gynecol Reprod Biol 2003; 108:137-41.
45. Mohlala BKF, Tucker TJ, Besser MJ, et al. Investigation of HIV in amniotic fluid from HIV-infected pregnant women at full term. J Infect Dis 2005; 192:488-91.
46. Mandelbrot L, Mayaux MJ, Bongain A, et al. Obstetric factors and mother-To-child transmission of human immunodeficiency virus type 1: The French perinatal cohorts. SEROGEST French Pediatric HIV Infection Study Group. Am J Obstet Gynecol 1996; 175:661-7.
47. Shapiro DE, Sperling RS, Mandelbrot L, Britto P, Cunningham BE. Risk factors for perinatal human immunodeficiency virus transmission in patients receiving zidovudine prophylaxis. Pediatric AIDS Clinical Trials Group protocol 076 Study Group. Obstet Gynecol 1999; 94:897-908.
48. Tess BH, Rodrigues LC, Newell ML, Dunn DT, Lago TD. Breastfeeding, genetic, obstetric and other risk factors associated with motherto-child transmission of HIV-1 in Sao Paulo State, Brazil. Sao Paulo Collaborative Study for Vertical Transmission of HIV-1. Aids 1998; 12:513-20.
49. Kaneda T, Shiraki K, Hirano K, Nagata I. Detection of maternofetal transfusion by placental alkaline phosphatase levels. J Pediatr 1997; 130:730-5.
50. Lin HH, Kao JH, Hsu HY, Mizokami M, Hirano K, Chen DS. Least microtransfusion from mother to fetus in elective cesarean delivery. Obstet Gynecol 1996; 87:244-8.
51. Kwiek JJ, Mwapasa V, Milner DAJ, et al. Maternal-fetal microtransfusions and HIV-1 mother-To-child transmission in Malawi. PLOS Med 2006; 3:e10.
52. Kwiek JJ, Arney LA, Harawa V, et al. Maternal-fetal DNA admixture is associated with intrapartum mother-To-child transmission of HIV-1 in Blantyre, Malawi. J Infect Dis 2008; 197:1378-81.
53. Biggar RJ, Lee T-H, Wen L, et al. The role of transplacental microtransfusions of maternal lymphocytes in HIV transmission to newborns. AIDS 2008; 22:2251-6.
54. Lee T-H, Chafets DM, Biggar RJ, McCune JM, Busch MP. The role of transplacental microtransfusions of maternal lymphocytes in in utero HIV transmission. JAIDS 2010; 55:143-7.
55. Goedert JJ, Duliege AM, Amos CI, Felton S, Biggar RJ. High risk of HIV-1 infection for first-born twins. The International Registry of HIV-exposed Twins. Lancet 1991; 338:1471-5.
56. Duliege AM, Amos CI, Felton S, Biggar RJ, Goedert JJ. Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 frommothers to twins. International Registry of HIV-Exposed Twins. J Pediatr 1995; 126:625-32.
57. Mandelbrot L, Burgard M, Teglas JP, et al. Frequent detection of HIV-1 in the gastric aspirates of neonates born to HIV-infected mothers. AIDS 1999; 13:2143-9.
58. Ait-Khaled M, Lyall EG, Stainsby C, et al. Intrapartum mucosal exposure to human immunodeficiency virus type 1 (HIV-1) of infants born to HIV-1-infected mothers correlates with maternal plasma virus burden. J Infect Dis 1998; 177:1097-100.
59. Nielsen K, Boyer P, Dillon M, et al. Presence of human immunodeficiency virus (HIV) type 1 and HIV-1-specific antibodies in cervicovaginal secretions of infected mothers and in the gastric aspirates of their infants. J Infect Dis 1996; 173:1001-4.
60. Chuachoowong R, Shaffer N, SiriwasinW, et al. Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission. Bangkok Collaborative Perinatal HIV Transmission Study Group. J Infect Dis 2000; 181:99-106.
61. Panther LA, Tucker L, Xu C, Tuomala RE, Mullins JI, Anderson DJ. Genital tract human immunodeficiency virus type 1 (HIV-1) shedding and inflammation and HIV-1 env diversity in perinatal HIV-1 transmission. J Infect Dis 2000; 181:555-63.
62. Montano M, Russell M, Gilbert P, et al. Comparative prediction of perinatal human immunodeficiency virus type 1 transmission, using multiple virus load markers. J Infect Dis 2003; 188:406-13.
63. Tuomala RE, ODriscoll PT, Bremer JW, et al. Cell-Associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women. J Infect Dis 2003; 187:375-84.
64. Neveu D, Viljoen J, Bland RM, et al. Cumulative exposure to cell-free HIV in breast milk, rather than feeding pattern per se, identifies postnatally infected infants. Clin Infect Dis 2011; 52:819-25.
65. Thiry L, Sprecher-Goldberger S, Jonckheer T, et al. Isolation of AIDS virus from cell-free breast milk of three healthy virus carriers. Lancet 1985; 2:891-2.
66. Van de Perre P, Simonon A, Hitimana DG, et al. Infective and antiinfective properties of breastmilk from HIV-1-infected women. Lancet 1993; 341:914-8.
67. Gray L, Fiscus S, Shugars D. HIV-1 variants from a perinatal transmission pair demonstrate similar genetic and replicative properties in tonsillar tissues and peripheral blood mononuclear cells. AIDS Res Hum Retroviruses 2007; 23:1095-104.
68. Van Rompay KKA, Abel K, Lawson JR, et al. Attenuated poxvirusbased simian immunodeficiency virus (SIV) vaccines given in infancy partially protect infant and juvenile macaques against repeated oral challenge with virulent SIV. JAIDS 2005; 38:124-34.
69. Wahl A, Swanson MD, Nochi T, et al. Human breast milk and antiretrovirals dramatically reduce oral HIV-1 transmission in BLT humanized mice. PLOS Pathog 2012; 8:e1002732.
70. Semba RD, Kumwenda N, Hoover DR, et al. Human immunodeficiency virus load in breast milk, mastitis, and mother-To-child transmission of human immunodeficiency virus type 1. J Infect Dis 1999; 180:93-8.
71. Pillay K, Coutsoudis A, York D, Kuhn L, Coovadia HM. Cell-free virus in breast milk of HIV-1-seropositive women. JAIDS 2000; 24:330-6.
72. Rousseau CM, Nduati RW, Richardson BA, et al. Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease. J Infect Dis 2003; 187:741-7.
73. Rousseau CM, Nduati RW, Richardson BA, et al. Association of levels of HIV-1-infected breast milk cells and risk of mother-To-child transmission. J Infect Dis 2004; 190:1880-8.
74. Koulinska IN, Villamor E, Chaplin B, et al. Transmission of cell-free and cell-Associated HIV-1 through breast-feeding. JAIDS 2006; 41:93-9.
75. Kantarci S, Koulinska IN, Aboud S, Fawzi WW, Villamor E. Subclinical mastitis, cell-Associated HIV-1 shedding in breast milk, and breastfeeding transmission of HIV-1. JAIDS 2007; 46:651-4.
76. Semrau K, Ghosh M, Kankasa C, et al. Temporal and lateral dynamics of HIV shedding and elevated sodium in breast milk among HIVpositive mothers during the first 4 months of breast-feeding. JAIDS 2008; 47:320-8.
77. Lunney KM, Iliff P, Mutasa K, et al. Associations between breast milk viral load, mastitis, exclusive breast-feeding, and postnatal transmission of HIV. Clin Infect Dis 2010; 50:762-9.
78. Ndirangu J, Viljoen J, Bland RM, et al. Cell-free (RNA) and cell-Associated (DNA) HIV-1 and postnatal transmission through breastfeeding. PLOS One 2012; 7:e51493.
79. Kuhn L, Kim H-Y, Walter J, et al. HIV-1 concentrations in human breast milk before and after weaning. Sci Transl Med 2013; 5:181ra51.
80. Lyimo MA, Howell AL, Balandya E, Eszterhas SK, Connor RI. Innate factors in human breast milk inhibit cell-free HIV-1 but not cell-Associated HIV-1 infection of CD4+ cells. JAIDS 2009; 51:117-24.
81. Fouda GG, Jaeger FH, Amos JD, et al. Tenascin-C is an innate broadspectrum, HIV-1-neutralizing protein in breast milk. PNAS 2013; 110:18220-25.
82. Habte HH, De Beer C, Lotz ZE, Tyler MG, Kahn D, Mall AS. Inhibition of human immunodeficiency virus type 1 activity by purified human breast milk mucin (MUC1) in an inhibition assay. Neonatology 2008; 93:162-70.
83. Wahl SM, McNeely TB, Janoff EN, et al. Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I. Oral Dis 1997; 3(suppl 1):S64-9.
84. Valenti P, Antonini G. Lactoferrin: An important host defence against microbial and viral attack. Cell Mol Life Sci 2005; 62:2576-87.
85. Wang W, Owen SM, Rudolph DL, et al. Activity of alpha-And thetadefensins against primary isolates of HIV-1. J Immunol 2004; 173:515-20.
86. Kazmi SH, Naglik JR, Sweet SP, et al. Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids. Clin Vaccine Immunol 2006; 13: 1111-8.
87. Lyimo MA, Mosi MN, Housman ML, et al. Breast milk from Tanzanian women has divergent effects on cell-free and cell-Associated HIV-1 infection in vitro. PLOS One 2012; 7:e43815.
88. Farquhar C, VanCott TC, Mbori-Ngacha DA, et al. Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milk. J Infect Dis 2002; 186:1173-6.
89. Becquart P, Grésenguet G, Hocini H, Kazatchkine MD, Belec L. Secretory leukocyte protease inhibitor in colostrum and breast milk is not a major determinant of the protection of early postnatal transmission of HIV. AIDS 1999; 13:2599-602.
90. Pillay K, Coutsoudis A, Agadzi-Naqvi AK, Kuhn L, Coovadia HM, Janoff EN. Secretory leukocyte protease inhibitor in vaginal fluids and perinatal human immunodeficiency virus type 1 transmission. J Infect Dis 2001; 183:653-6.
91. Lohman-Payne B, Slyker JA, Moore S, et al. Breast milk cellular HIVspecific interferon gamma responses are associated with protection from peripartum HIV transmission. AIDS 2012; 26:2007-16.
92. Mabuka J, Nduati R, Odem-Davis K, Peterson D, Overbaugh J. HIVspecific antibodies capable of ADCC are common in breastmilk and are associated with reduced risk of transmission in women with high viral loads. PLOS Pathog 2012; 8:e1002739.
93. Ferrantelli F, Rasmussen RA, Buckley KA, et al. Complete protection of neonatal rhesus macaques against oral exposure to pathogenic simian-human immunodeficiency virus by human anti-HIV monoclonal antibodies. J Infect Dis 2004; 189:2167-73.
94. Van Rompay KK, Berardi CJ, Dillard-Telm S, et al. Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection. J Infect Dis 1998; 177:1247-59.
95. Hessell AJ, Hangartner L, Hunter M, et al. Fc receptor but not complement binding is important in antibody protection against HIV. Nature 2007; 449:101-4.
96. Overbaugh J, Morris L. The antibody response against HIV-1. Cold Spring Harb Perspect Med 2012; 2:a007039.
97. Overbaugh J. Mother-infant HIV transmission: do maternal HIVspecific antibodies protect the infant? PLOS Pathog. In Press.
98. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment.: Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 331:1173-80.
99. Kumwenda NI, Hoover DR, Mofenson LM, et al. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med 2008; 359:119-29.
100. Chasela CS, Hudgens MG, Jamieson DJ, et al. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med 2010; 362:2271-81.
101. Chung MH, Kiarie JN, Richardson BA, et al. Independent effects of nevirapine prophylaxis and HIV-1 RNA suppression in breast milk on early perinatal HIV-1 transmission. JAIDS 2007; 46:472-8.
102. Slyker JA, Chung MH, Lehman DA, et al. Incidence and correlates of HIV-1 RNA detection in the breast milk of women receiving HAART for the prevention of HIV-1 transmission. PLOS One 2012; 7:e29777.
103. Lehman DA, Chung MH, John-Stewart GC, et al. HIV-1 persists in breast milk cells despite antiretroviral treatment to prevent motherto-child transmission. AIDS 2008; 22:1475-85.
104. Shapiro RL, Ndungu T, Lockman S, et al. Highly active antiretroviral therapy started during pregnancy or postpartum suppresses HIV-1 RNA, but not DNA, in breast milk. J Infect Dis 2005; 192:713-9.
105. Graham SM, Holte SE, Peshu NM, et al. Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding. AIDS 2007; 21:501-7.
106. Nunnari G, Sullivan J, Xu Y, et al. HIV type 1 cervicovaginal reservoirs in the era of HAART. AIDS Res Hum Retroviruses 2005; 21:714-8.
107. Manigart O, Crepin M, Leroy V, et al. Effect of perinatal zidovudine prophylaxis on the evolution of cell-free HIV-1 RNA in breast milk and on postnatal transmission. J Infect Dis 2004; 190:1422-8.
108. Chung MH, Kiarie JN, Richardson BA, Lehman DA, Overbaugh J, John-Stewart GC. Breast milk HIV-1 suppression and decreased transmission: A randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine. AIDS 2005; 19:1415-22.
109. Arvold ND, Ngo-Giang-Huong N, McIntosh K, et al. Maternal HIV-1 DNA load and mother-To-child transmission. AIDS Patient Care STDS 2007; 21:638-43.
110. Garrigue I, Pellegrin I, Hoen B, et al. Cell-Associated HIV-1-DNA quantitation after highly active antiretroviral therapy-Treated primary infection in patients with persistently undetectable plasma HIV-1 RNA. AIDS 2000; 14:2851-5.
111. Eriksson S, Graf EH, Dahl V, et al. Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies. PLOS Pathog 2013; 9:e1003174.